OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT00036647 · COMPLETED

Trial details

NCT number: NCT00036647
Sponsor: OSI Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-small-cell Lung

Start date: 2001-11-01
Primary completion: 2004-01-30
Enrollment: 731

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.